Literature DB >> 34547437

Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal.

A Shaukat1, T L Marsh2, S D Crockett3, S Syngal4, R S Bresalier5, D E Brenner6.   

Abstract

Prior studies have reported the prevalence of colorectal cancer (CRC) in average-risk screening population ages 50-75 to be 0.7%-1.0%.1,2 However, no estimates from studies enrolling individuals undergoing screening colonoscopy have been reported. The experience of ongoing studies enrolling average-risk individuals is that the prevalence rates are substantially lower. A 2020 study from a community-based cohort undergoing CRC screening with fecal immunochemical testing followed by diagnostic colonoscopy reported a CRC prevalence rate of 1.46 per 1000, or 0.15%.3 The aim of our study is to report the screen-detected prevalence of CRC and advanced neoplasia in average-risk asymptomatic individuals from selected academic and community medical centers in the United States, Canada, and Germany and describe associated risk factors.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34547437      PMCID: PMC8934307          DOI: 10.1016/j.cgh.2021.09.013

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  9 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  2008-04       Impact factor: 6.437

2.  Multitarget stool DNA testing for colorectal-cancer screening.

Authors:  Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

3.  Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Authors:  William E Barlow; Elisabeth F Beaber; Berta M Geller; Aruna Kamineni; Yingye Zheng; Jennifer S Haas; Chun R Chao; Carolyn M Rutter; Ann G Zauber; Brian L Sprague; Ethan A Halm; Donald L Weaver; Jessica Chubak; V Paul Doria-Rose; Sarah Kobrin; Tracy Onega; Virginia P Quinn; Marilyn M Schapira; Anna N A Tosteson; Douglas A Corley; Celette Sugg Skinner; Mitchell D Schnall; Katrina Armstrong; Cosette M Wheeler; Michael J Silverberg; Bijal A Balasubramanian; Chyke A Doubeni; Dale McLerran; Jasmin A Tiro
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

4.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Authors:  D A Lieberman; D G Weiss; J H Bond; D J Ahnen; H Garewal; G Chejfec
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

5.  Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals.

Authors:  David A Lieberman; J Lucas Williams; Jennifer L Holub; Cynthia D Morris; Judith R Logan; Glenn M Eisen; Patricia Carney
Journal:  Gastroenterology       Date:  2014-04-29       Impact factor: 22.682

6.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Authors:  Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

7.  Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.

Authors:  David A Lieberman; Sheila Prindiville; David G Weiss; Walter Willett
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

8.  Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jolanda de Boer; Theodore R Levin; Chyke Doubeni; Bruce H Fireman; Charles P Quesenberry
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

9.  Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.

Authors:  Timothy Robert Church; Michael Wandell; Catherine Lofton-Day; Steven J Mongin; Matthias Burger; Shannon R Payne; Esmeralda Castaños-Vélez; Brent A Blumenstein; Thomas Rösch; Neal Osborn; Dale Snover; Robert W Day; David F Ransohoff
Journal:  Gut       Date:  2013-02-13       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.